Neurostimulation Devices Market to 2018 - Technological Advances and Robust Pipeline with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth
Publisher Name » GBI Research
Published Date » 2012-07-31
No. Of Pages » 103
GBI Researchs report, Neurostimulation Devices Market to 2018 Technological Advances and Robust Pipeline with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth, provides key data, information and analysis on the global neurostimulation devices market. The report provides the market landscape, competitive landscape and market trend information on five neurostimulation device market segments: cortical stimulators, deep brain stimulators, sacral nerve stimulators, spinal cord stimulators and vagus nerve stimulators. The report provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape and provides a detailed analysis of the pipeline products in each segment. It also reviews details about important merger and acquisition deals that have taken place in the neurostimulation devices market during the past five years. The report is compiled using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
- The market size of five neurostimulation device market segments: cortical stimulators, deep brain stimulators, sacral nerve stimulators, spinal cord stimulators and vagus nerve stimulators.
- Annualized market revenue data from 2004 to 2011, forecast forward for seven years to 2018.
- Qualitative analysis of key market trends, market drivers and restraints for each segment within the neurostimulation devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading technologies.
- Key players covered include: Medtronic, Inc., St. Jude Medical, Inc., Boston Scientific Corporation and Cyberonics, Inc.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the neurostimulation devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market entry and market expansion strategies.
- Identify key players best positioned to take advantage of emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
- Whats the next big thing in the neurostimulation devices market landscape? Identify, understand and capitalize.
- Make more informed business decisions with the aid of insightful and in-depth analysis of the global neurostimulation devices market and the factors shaping it.
Table Of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Executive Summary 11
2.1 The Global Neurostimulation Devices Market is Forecast to Witness High Growth During the Forecast Period 11
2.2 Medtronic is the Dominant Player in the Global Neurostimulation Devices Market 12
2.3 The Global Neurostimulation Devices Pipeline is Dominated by Deep Brain Stimulation Products 13
3 Introduction 14
3.1 GBI Research Guidance 14
4 Global Neurostimulation Devices Market: An Overview 16
4.1 Spinal Cord Stimulators 16
4.2 Deep Brain Stimulator 16
4.3 Vagus Nerve Stimulator 16
4.4 Sacral Nerve Stimulator 17
4.5 Cortical Stimulator 17
5 Global Neurostimulation Devices Market: Market Characterization 18
5.1 Global Neurostimulation Devices Market, Revenue ($m), 2004–2011 18
5.2 Global Neurostimulation Devices Market, Revenue ($m), 2011–2018 20
5.3 Global Neurostimulation Devices Market, Key Company Share (%), 2010 22
5.4 Global Neurostimulation Devices Market: Key Trends 23
5.4.1 Application of Neurostimulation Technology for Treatment with New Therapies 23
5.4.2 Increasing Investments by Private Equity and Venture Capital Firms in Start-up Companies 23
5.5 Global Neurostimulation Devices Market: Market Dynamics 26
5.5.1 Market Drivers 26
5.5.2 Market Restraints 29
6 Global Neurostimulation Devices Market: Segment Analysis and Forecasts 31
6.1 Spinal Cord Stimulators Market, Global, Revenue ($m), 2004–2011 31
6.2 Spinal Cord Stimulators Market, Global, Revenue ($m), 2011–2018 33
6.3 Spinal Cord Stimulators: Market Dynamics 34
6.3.1 Market Drivers 34
6.3.2 Market Restraints 35
6.4 Deep Brain Stimulators Market, Global, Revenue ($m), 2004–2011 37
6.5 Deep Brain Stimulators Market, Global, Revenue ($m), 2011–2018 39
6.6 Deep Brain Stimulators: Market Dynamics 40
6.6.1 Market Drivers 40
6.6.2 Market Restraints 41
6.7 Vagus Nerve Stimulators Market, Global, Revenue ($m), 2004–2011 42
6.8 Vagus Nerve Stimulators Market, Global, Revenue ($m), 2011–2018 43
6.9 Vagus Nerve Stimulators: Market Dynamics 45
6.9.1 Market Drivers 45
6.9.2 Market Restraints 46
6.10 Sacral Nerve Stimulators Market, Global, Revenue ($m), 2004–2011 47
6.11 Sacral Nerve Stimulators Market, Global, Revenue ($m), 2011–2018 49
6.12 Sacral Nerve Stimulators: Market Dynamics 50
6.12.1 Market Drivers 50
6.12.2 Market Restraints 50
6.13 Cortical Stimulators Market, Global, Revenue ($m), 2004–2011 51
6.14 Cortical Stimulators Market, Global, Revenue ($m), 2011–2018 53
6.15 Cortical Stimulators: Market Dynamics 54
6.15.1 Market Drivers 54
6.15.2 Market Restraints 54
7 Global Neurostimulation Devices Market: Country Analysis and Forecasts 56
7.1 Neurostimulation Devices Market: Cross Country Analysis 56
7.2 Historic and Forecast Revenue, By Country 58
7.2.1 Neurostimulation Devices Market, the US, Revenue ($m), 2004–2011 58
7.2.2 Neurostimulation Devices Market, the US, Revenue ($m), 2011–2018 59
7.2.3 Neurostimulation Devices Market, Canada, Revenue ($m), 2004–2011 61
7.2.4 Neurostimulation Devices Market, Canada, Revenue ($m), 2011–2018 63
7.2.5 Neurostimulation Devices Market, the UK, Revenue ($m), 2004–2011 65
7.2.6 Neurostimulation Devices Market, the UK, Revenue ($m), 2011–2018 67
7.2.7 Neurostimulation Devices Market, Germany, Revenue ($m), 2004–2011 69
7.2.8 Neurostimulation Devices Market, Germany, Revenue ($m), 2011–2018 71
7.2.9 Neurostimulation Devices Market, France, Revenue ($m), 2004–2011 73
7.2.10 Neurostimulation Devices Market, France, Revenue ($m), 2011–2018 75
7.2.11 Neurostimulation Devices Market, Italy, Revenue ($m), 2004–2011 77
7.2.12 Neurostimulation Devices Market, Italy, Revenue ($m), 2011–2018 79
7.2.13 Neurostimulation Devices Market, Spain, Revenue ($m), 2004–2011 81
7.2.14 Neurostimulation Devices Market, Spain, Revenue ($m), 2011–2018 83
7.2.15 Neurostimulation Devices Market, Japan, Revenue ($m), 2004–2011 85
7.2.16 Neurostimulation Devices Market, Japan, Revenue ($m), 2011–2018 87
7.2.17 Neurostimulation Devices Market, China, Revenue ($m), 2004–2011 89
7.2.18 Neurostimulation Devices Market, China, Revenue ($m), 2011–2018 91
7.2.19 Neurostimulation Devices Market, India, Revenue ($m), 2004–2011 93
7.2.20 Neurostimulation Devices Market, India, Revenue ($m), 2011–2018 95
7.2.21 Neurostimulation Devices Market, Australia, Revenue ($m), 2004–2011 97
7.2.22 Neurostimulation Devices Market, Australia, Revenue ($m), 2011–2018 99
7.2.23 Neurostimulation Devices Market, Brazil, Revenue ($m), 2004–2011 101
7.2.24 Neurostimulation Devices Market, Brazil, Revenue ($m), 2011–2018 103
8 Global Neurostimulation Devices Market: Competitive Assessment 106
8.1 Medtronic, Inc. 106
8.1.1 Business Overview 107
8.1.2 Key Marketed Products 107
8.2 St. Jude Medical, Inc. 108
8.2.1 Business Overview 109
8.2.2 Key Marketed Products 109
8.3 Boston Scientific Corporation 110
8.3.1 Business Overview 110
8.3.2 Key Marketed Products 110
8.4 Cyberonics, Inc. 111
8.4.1 Business Overview 111
8.4.2 Key Marketed Products 112
9 Global Neurostimulation Devices Market: Pipeline Analysis 113
9.1 Introduction 113
9.1.1 Neurostimulation Devices: Pipeline Assessment, by Segment 113
9.1.2 Neurostimulation Devices: Pipeline Assessment, by Stage of Development 115
9.1.3 Neurostimulation Devices: Pipeline Assessment 116
9.2 Spinal Cord Stimulators: Product Pipeline 116
9.2.1 Spinal Cord Stimulators: List of Pipeline Products 116
9.2.2 Spinal Cord Stimulators: Profiles of Key Pipeline Products 117
9.3 Deep Brain Stimulators: Product Pipeline 120
9.3.1 Deep Brain Stimulators: List of Pipeline Products 120
9.3.2 Deep Brain Stimulators: Profiles of Key Pipeline Products 121
9.4 Vagus Nerve Stimulators: Product Pipeline 126
9.4.1 Vagus Nerve Stimulators: List of Pipeline Products 126
9.4.2 Vagus Nerve Stimulators: Profiles of Key Pipeline Products 127
9.5 Sacral Nerve Stimulators: Product Pipeline 130
9.5.1 Sacral Nerve Stimulators: List of Pipeline Products 130
9.5.2 Sacral Nerve Stimulators: Profiles of Key Pipeline Products 131
9.6 Cortical Stimulators: Product Pipeline 132
9.6.1 Cortical Stimulators: List of Pipeline Products 132
9.6.2 Cortical Stimulators: Profiles of Key Pipeline Products 132
9.7 Other Neurostimulation Devices – Product Pipeline 133
9.7.1 Other Neurostimulation Devices – List of Pipeline Products 133
10 Global Neurostimulation Devices Market: Consolidation Landscape 138
10.1 Neurostimulation Devices Market: Deals by Number and Deal Value, 2007–2012 138
10.2 Key Mergers and Acquisitions 2012 (Q1, Q2) 140
10.2.1 Greatbatch Acquires NeuroNexus Technologies 140
10.3 Key Mergers and Acquisitions: 2007–2011 141
10.3.1 Boston Scientific’s Acquisition of Intelect Medical 141
10.3.2 Otto Bock HealthCare’s Acquisition of Neurostream Technologies from Victhom Human Bionics 141
10.3.3 St. Jude Medical’s Acquisition of Northstar Neuroscience 142
10.3.4 Medtronic’s Acquisition of NDI’s Medstim System 142
10.3.5 Greatbatch’s Acquisition of Quan Emerteq 143
10.3.6 Greatbatch’s Acquisition of Enpath Medical 143
10.4 Key Partnership Deals: 2007–2010 144
10.4.2 Ardiem Medical’s Licensing Agreement with Case Western Reserve University 144
10.4.3 Neurowave Medical Technologies’ Licensing Agreement with Alaven Pharma 145
10.4.4 Cyberonics’ Licensing Agreement with NeuroVista 145
10.4.5 Victhom Human Bionics’ Joint Venture Agreement with Otto Bock HealthCare 145
10.4.6 Cyberonics’ Agreement with Nihon Kohden 146
10.4.7 Cyberonics’ Licensing Agreement with Massachusetts Institute of Technology 146
10.4.8 NeuroNexus Technologies’ Research Agreement with Philips Research 146
10.4.9 Intelect Medical’s Agreement with Boston Scientific 146
10.4.10 Cyberonics’ Licensing Agreement with Southern Illinois University 146
10.4.11 Cyberonics’ Licensing Agreement with Ethicon Endo-Surgery 147
10.4.12 Innovative Neurotronics’ Agreement with Teijin Pharma 147
11 Appendix 148
11.1 Definitions 148
11.1.1 Neurostimulation Devices 148
11.1.2 Prevalence or Diseased Population 149
11.2 Sources 149
11.3 Acronyms 149
11.4 Research Methodology 152
11.4.1 Secondary Research 152
11.4.2 Primary Research 152
11.4.3 Models 153
11.4.4 Forecasts 153
11.4.5 Expert Panels 153
11.5 Contact Us 154
11.6 Disclaimer 154
List of Tables
Table 1: Neurostimulation Devices Market, Global, Revenue ($m), 2004-2011 14
Table 2: Neurostimulation Devices Market, Global, Revenue ($m), 2011-2018 16
Table 3: Neurostimulation Devices Market, Global, Key Company Revenue ($m), 2010 17
Table 4: Neurostimulation Devices Market, Global, Private Equity and Venture Capital Deals, 2011-2012 19
Table 5: Neurostimulation Devices Market, Global, Product Approvals, 2011 21
Table 6: Neurostimulation Devices Market, Global, Product Recalls, 2010-2012 22
Table 7: Spinal Cord Stimulators Market, Global, Revenue ($m), 2004-2011 24
Table 8: Spinal Cord Stimulators Market, Global, Revenue ($m), 2011-2018 25
Table 9: Deep Brain Stimulators Market, Global, Revenue ($m), 2004-2011 28
Table 10: Deep Brain Stimulators Market, Global, Revenue ($m), 2011-2018 29
Table 11: Vagus Nerve Stimulators Market, Global, Revenue ($m), 2004-2011 31
Table 12: Vagus Nerve Stimulators Market, Global, Revenue ($m), 2011-2018 32
Table 13: Sacral Nerve Stimulators Market, Global, Revenue ($m), 2004-2011 34
Table 14: Sacral Nerve Stimulators Market, Global, Revenue ($m), 2011-2018 35
Table 15: Cortical Stimulators Market, Global, Revenue ($m), 2004-2011 37
Table 16: Cortical Stimulators Market, Global, Revenue ($m), 2011-2018 38
Table 17: Neurostimulation Devices Market: Cross Country Analysis, Global, CAGR (%), 2004-2018 40
Table 18: Neurostimulation Devices Market, the US, Revenue ($m), 2004-2011 42
Table 19: Neurostimulation Devices Market, the US, Revenue ($m), 2011-2018 43
Table 20: Neurostimulation Devices Market, Canada, Revenue ($m), 2004-2011 44
Table 21: Neurostimulation Devices Market, Canada, Revenue ($m), 2011-2018 45
Table 22: Neurostimulation Devices Market, the UK, Revenue ($m), 2004-2011 46
Table 23: Neurostimulation Devices Market, the UK, Revenue ($m), 2011-2018 47
Table 24: Neurostimulation Devices Market, Germany, Revenue ($m), 2004-2011 48
Table 25: Neurostimulation Devices Market, Germany, Revenue ($m), 2011-2018 49
Table 26: Neurostimulation Devices Market, France, Revenue ($m), 2004-2011 50
Table 27: Neurostimulation Devices Market, France, Revenue ($m), 2011-2018 51
Table 28: Neurostimulation Devices Market, Italy, Revenue ($m), 2004-2011 52
Table 29: Neurostimulation Devices Market, Italy, Revenue ($m), 2011-2018 53
Table 30: Neurostimulation Devices Market, Spain, Revenue ($m), 2004-2011 54
Table 31: Neurostimulation Devices Market, Spain, Revenue ($m), 2011-2018 55
Table 32: Neurostimulation Devices Market, Japan, Revenue ($m), 2004-2011 56
Table 33: Neurostimulation Devices Market, Japan, Revenue ($m), 2011-2018 57
Table 34: Neurostimulation Devices Market, China, Revenue ($m), 2004-2011 58
Table 35: Neurostimulation Devices Market, China, Revenue ($m), 2011-2018 59
Table 36: Neurostimulation Devices Market, India, Revenue ($m), 2004-2011 60
Table 37: Neurostimulation Devices Market, India, Revenue ($m), 2011-2018 61
Table 38: Neurostimulation Devices Market, Australia, Revenue ($m), 2004-2011 62
Table 39: Neurostimulation Devices Market, Australia, Revenue ($m), 2011-2018 63
Table 40: Neurostimulation Devices Market, Brazil, Revenue ($m), 2004-2011 64
Table 41: Neurostimulation Devices Market, Brazil, Revenue ($m), 2011-2018 65
Table 42: Neurostimulation Devices Market, Global, Key Marketed Products - Medtronic, 2012 67
Table 43: Neurostimulation Devices Market, Global, Key Marketed Products - St. Jude Medical, 2012 68
Table 44: Neurostimulation Devices Market, Global, Key Marketed Products - Boston Scientific, 2012 69
Table 45: Neurostimulation Devices Market, Global, Key Marketed Products - Cyberonics, 2012 70
Table 46: Neurostimulation Devices Market, Global, Pipeline Analysis, by Segment, 2012 71
Table 47: Neurostimulation Devices Market, Global, Pipeline Analysis, by Stage of Development, 2012 72
Table 48: Neurostimulation Devices Market, Spinal Cord Stimulators, Global, List of Pipeline Products, 2012 73
Table 49: Neurostimulation Devices Market, Pipeline Analysis - PrimeADVANCED, 2012 74
Table 50: Neurostimulation Devices Market, Pipeline Analysis - Genesis Neurostimulation System, 2012 74
Table 51: Neurostimulation Devices Market, Pipeline Analysis - SAINT System, 2012 75
Table 52: Neurostimulation Devices Market, Global, Pipeline Analysis - Next Generation SCS System, 2012 75
Table 53: Neurostimulation Devices Market, Pipeline Analysis - Precision Plus SCS System, 2012 76
Table 54: Neurostimulation Devices Market, Deep Brain Stimulators, Global, List of Pipeline Products, 2012 77
Table 55: Neurostimulation Devices Market, Pipeline Analysis - Activa PC, 2012 78
Table 56: Neurostimulation Devices Market, Pipeline Analysis - CR-Capable Implant, 2012 78
Table 57: Neurostimulation Devices Market, Pipeline Analysis - Enspire DBS Therapy System, 2012 78
Table 58: Neurostimulation Devices Market, Pipeline Analysis - ESStim 101, 2012 79
Table 59: Neurostimulation Devices Market, Pipeline Analysis - Libra Deep Brain Stimulation System, 2012 79
Table 60: Neurostimulation Devices Market, Pipeline Analysis - Vercise DBS System, 2012 80
Table 61: Neurostimulation Devices Market, Pipeline Analysis - directSTIM, 2012 80
Table 62: Neurostimulation Devices Market, Pipeline Analysis - spiderSTIM, 2012 80
Table 63: Neurostimulation Devices Market, Pipeline Analysis - Synapse, 2012 81
Table 64: Neurostimulation Devices Market, Vagus Nerve Stimulators, Global, List of Pipeline Products, 2012 82
Table 65: Neurostimulation Devices Market, Pipeline Analysis - Aspire NP, 2012 83
Table 66: Neurostimulation Devices Market, Pipeline Analysis- FitNes System, 2012 84
Table 67: Neurostimulation Devices Market, Pipeline Analysis - SAINT System, 2012 84
Table 68: Neurostimulation Devices Market, Pipeline Analysis - NEMOS, 2012 84
Table 69: Neurostimulation Devices Market, Pipeline Analysis - Pulse Generator, 2012 85
Table 70: Neurostimulation Devices Market, Sacral Nerve Stimulators, Global, List of Pipeline Products, 2012 85
Table 71: Neurostimulation Devices Market, Pipeline Analysis - Sacral Nerve Stimulation Device, 2012 85
Table 72: Neurostimulation Devices Market, Pipeline Analysis - SAINT System, 2012 86
Table 73: Neurostimulation Devices Market, Pipeline Analysis - Verv System, 2012 86
Table 74: Neurostimulation Devices Market, Cortical Stimulators, Global, List of Pipeline Products, 2012 87
Table 75: Neurostimulation Devices Market, Pipeline Analysis - cortiSTIM, 2012 87
Table 76: Neurostimulation Devices Market, Other Neurostimulation Devices, Global, List of Pipeline Products, Table 1, 2012 88
Table 77: Neurostimulation Devices Market, Other Neurostimulation Devices, Global, List of Pipeline Products, Table 2, 2012 89
Table 78: Neurostimulation Devices Market, Other Neurostimulation Devices, Global, List of Pipeline Products, Table 3, 2012 90
Table 79: Neurostimulation Devices Market, Global, Key Mergers and Acquisitions, by Number of Deals and Deal Value ($m), 2007-2012 92
Table 80: Neurostimulation Devices Market, Global, Key Mergers and Acquisitions, 2007-2011 93
Table 81: Neurostimulation Devices Market, Global, Key Partnership Deals, 2007-2010 95
List of Figures
Figure 1: Neurostimulation Devices Market, Global, Revenue ($m), 2004-2011 14
Figure 2: Neurostimulation Devices Market, Global, Revenue ($m), 2011-2018 15
Figure 3: Neurostimulation Devices Market, Global, Key Company Share (%), 2010 17
Figure 4: Neurostimulation Devices Market, Potential for the Treatment of Various Indications, 2012 18
Figure 5: Neurostimulation Devices Market, Global, Population of Elderly (%), By 2020 21
Figure 6: Spinal Cord Stimulators Market, Global, Revenue ($m), 2004-2011 24
Figure 7: Spinal Cord Stimulators Market, Global, Revenue ($m), 2011-2018 25
Figure 8: Deep Brain Stimulators Market, Global, Revenue ($m), 2004-2011 27
Figure 9: Deep Brain Stimulators Market, Global, Revenue ($m), 2011-2018 29
Figure 10: Vagus Nerve Stimulators Market, Global, Revenue ($m), 2004-2011 31
Figure 11: Vagus Nerve Stimulators Market, Global, Revenue ($m), 2011-2018 32
Figure 12: Sacral Nerve Stimulators Market, Global, Revenue ($m), 2004-2011 34
Figure 13: Sacral Nerve Stimulators Market, Global, Revenue ($m), 2011-2018 35
Figure 14: Cortical Stimulators Market, Global, Revenue ($m), 2004-2011 37
Figure 15: Cortical Stimulators Market, Global, Revenue ($m), 2011-2018 38
Figure 16: Neurostimulation Devices Market: Cross Country Analysis, Global, CAGR (%), 2004-2018 40
Figure 17: Neurostimulation Devices Market, the US, Revenue ($m), 2004-2011 41
Figure 18: Neurostimulation Devices Market, the US, Revenue ($m), 2011-2018 43
Figure 19: Neurostimulation Devices Market, Canada, Revenue ($m), 2004-2011 44
Figure 20: Neurostimulation Devices Market, Canada, Revenue ($m), 2011-2018 45
Figure 21: Neurostimulation Devices Market, the UK, Revenue ($m), 2004-2011 46
Figure 22: Neurostimulation Devices Market, the UK, Revenue ($m), 2011-2018 47
Figure 23: Neurostimulation Devices Market, Germany, Revenue ($m), 2004-2011 48
Figure 24: Neurostimulation Devices Market, Germany, Revenue ($m), 2011-2018 49
Figure 25: Neurostimulation Devices Market, France, Revenue ($m), 2004-2011 50
Figure 26: Neurostimulation Devices Market, France, Revenue ($m), 2011-2018 51
Figure 27: Neurostimulation Devices Market, Italy, Revenue ($m), 2004-2011 52
Figure 28: Neurostimulation Devices Market, Italy, Revenue ($m), 2011-2018 53
Figure 29: Neurostimulation Devices Market, Spain, Revenue ($m), 2004-2011 54
Figure 30: Neurostimulation Devices Market, Spain, Revenue ($m), 2011-2018 55
Figure 31: Neurostimulation Devices Market, Japan, Revenue ($m), 2004-2011 56
Figure 32: Neurostimulation Devices Market, Japan, Revenue ($m), 2011-2018 57
Figure 33: Neurostimulation Devices Market, China, Revenue ($m), 2004-2011 58
Figure 34: Neurostimulation Devices Market, China, Revenue ($m), 2011-2018 59
Figure 35: Neurostimulation Devices Market, India, Revenue ($m), 2004-2011 60
Figure 36: Neurostimulation Devices Market, India, Revenue ($m), 2011-2018 61
Figure 37: Neurostimulation Devices Market, Australia, Revenue ($m), 2004-2011 62
Figure 38: Neurostimulation Devices Market, Australia, Revenue ($m), 2011-2018 63
Figure 39: Neurostimulation Devices Market, Brazil, Revenue ($m), 2004-2011 64
Figure 40: Neurostimulation Devices Market, Brazil, Revenue ($m), 2011-2018 65
Figure 41: Neurostimulation Devices Market, Global, Competitive Assessment, 2012 66
Figure 42: Neurostimulation Devices Market, Global, Pipeline Analysis, by Segment (%), 2012 71
Figure 43: Neurostimulation Devices Market, Global, Pipeline Analysis, by Stage of Development (%), 2012 72
Figure 44: Neurostimulation Devices Market, Global, Pipeline Assessment, Analytics Framework, 2012 73
Figure 45: Neurostimulation Devices Market, Global, Key Mergers and Acquisitions, by Number of Deals and Deal Value ($m), 2007-2012 91
Upcoming Reports:
|
Modified Starch Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
By - Transparency Market Research
Changing the properties of starch is referred to as modified starch. It is prepared by modifying and adding other natural variants and chemicals to native starch. Modified starch is used in many applications such as in food as a thickening substance, as emulsifier in the pharmaceutical sector and as a binder in coated paper.
The modified starch market could be segmented into three major categories, on the basis of types into: etherified starch, esterified starch, resistant starch and pre-gelatinized starch, on the basis of raw material into: corn, wheat, potato, cassava and...
|
|
Apheresis Market (Therapeutic Apheresis & Donor Apheresis) - Global Forecast, Market Share, Size, Growth And Industry Analysis, 2012 - 2018
By - Transparency Market Research
Apheresis, also called as hemapheresis and pheresis is a procedure which involves withdrawal of blood from a donor and separation and retention of its components such as plasma, platelets, leukocytes, and others. Thereafter, the remaining components are transfused back into the donor.
Thus therapeutic apheresis is a procedure of separation of blood into its components and also includes removal of abnormal components. The overall apheresis market is classified from the perspective of donor apheresis and therapeutic apheresis.
Increase in health awareness,...
|
|
Electroactive Polymers Market - Global Industry Analysis, Size, Growth, Share, And Forecast, 2012 - 2018
By - Transparency Market Research
Polymers exhibiting change in their size and shape in the presence of an electric field are referred to as electroactive polymers. They are most commonly used in sensors and actuators, as they can withstand large force. Conductive plastics emerged as the leading type of electroactive polymer which accounted for approximately 84.2% of the total electroactive market revenue in 2011.
North America was the biggest market for electroactive polymers followed by Europe and Asia Pacific. Some of the major factors driving the global market for electroactive polymers include...
|
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
Select License type:
Share this report
Latest Reports
- The Future of the Haircare Market in Egypt to 2017
- The Future of the Haircare Market in Denmark to 2017
- The Future of the Haircare Market in Czech Republic to 2017
- The Future of the Haircare Market in Canada to 2017
- China Ophthalmic Hospital Industry Report, 2012 - 2015
- Global Food Industry Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Food Industry
- The Future of the Haircare Market in Bulgaria to 2017
- Electricity Meters (Smart Meters) Market For Residential, Commercial And Industrial Applications - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
- Bed Linen Markets in the World to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Europe to 2017 - Market Size, Trends, and Forecasts
Related News
|
One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
|
|
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples.
The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
|
|
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
|
|
Battling against flu, vaccination necessary for health workers
Sep 14, 2012
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease.
Health officials...
|
|
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...
|
